Besivance eye drop approved to treat bacterial conjunctivitis


Know more about
Conjunctivitis
Besivance eye drop approved to treat bacterial conjunctivitis

The U.S. Food and Drug Administration approved Besivance (besifloxacin ophthalmic suspension 0.6 percent) for the treatment of bacterial conjunctivitis (non-viral), a contagious condition marked by irritation of the eyes and a discharge from the mucous membranes.

"Bacterial conjunctivitis is a common condition that affects people of all ages," said Wiley A. Chambers, M.D., acting director of the Division of Anti-Infective and Ophthalmology Products in FDA's Center for Drug Evaluation and Research.

"It is important to have a variety of treatment options available to health care professionals and patients because an effective drug therapy can reduce the duration of the illness and reduce the chances of infecting others."

Bacterial forms of conjunctivitis are common in childhood, but they can occur in people of any age. Symptoms of bacterial conjunctivitis can include red eyes, swelling, eyelids sticking together, itching, watering and a white or yellow sticky discharge from the eyes. Bacterial conjunctivitis is generally a condition that runs its course in 7-14 days.

Patients using the drug in clinical trials had a faster rate of resolution of the infection than those treated with a solution containing only a preservative. The drug was shown to be effective in treating patients age one year and older.

Adverse events were reported in less than 3 percent of patients in clinical trials. Adverse reactions included redness of the eyes, blurred vision, eye pain, irritation and itching, and headache. Besivance is an eye drop for topical use on the eyes only. It should not be injected into the eye.

Besivance is made by Bausch & Lomb, Rochester, N.Y.


(Editor compiled and published Besivance eye drop approved to treat bacterial conjunctivitis at HealthNewsTrack on May 29, 2009 sourced from U.S. Food and Drug Administration - http://www.fda.gov/)

Conjunctivitis article/news source:

Read more health articles from U.S. Food and Drug Administration and health articles from USA.

Conjunctivitis - search related terms:

Allergic reaction, Bacterial conjunctivitis, Conjunctiva, Conjunctivitis, Eye drop, Eyelid, Infection, Ophthalmology,
Conjunctivitis books,

Searched keywords: besivance eye drops (84),

Mission
Health Newstrack is dedicated to serve recent and updated health & medical research, events/news, views/reviews to its subscribers and free access to general public, health & medical professionals, and other health seekers worldwide online with a user-friendly system.


Subscribe to Health News by Email

Current news
U.S. Food and Drug Administration (FDA) Approves Besivance to Treat Bacterial Conjunctivitis

Conjunctivitis
About Conjunctivitis
Conjuctivitis is an inflammation or redness of the lining of the white part of the eye and the underside of the eyelid (conjunctiva) that can be caused by infection, allergic reaction, or physical agents like infrared or ultra-violet light.


List health news, Health organizations, Health news world, Glossary, Best health articles, Featured     Go to top

The information provided on Health Newstrack is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician. We comply with the HONcode principles for trustworthy health information, and Health News Track is hon code accredited, verify here.
About us, Site map Privacy policy, Disclaimer
© 2007, 2008, 2009, 2010, 2011 HealthNewsTrack.com
2.36